These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 2448632

  • 1. Behavioral interaction between endogenous opioids, CCK-8 and dopaminergic systems in the nucleus accumbens of rats.
    van Ree JM, Igarashi J, Király I.
    NIDA Res Monogr; 1986; 75():323-6. PubMed ID: 2448632
    [Abstract] [Full Text] [Related]

  • 2. Behavioral evidence for the involvement of endogenous opioids in the interaction between cholecystokinin and brain dopamine systems.
    Király I, Van Ree JM.
    Neurosci Lett; 1987 Mar 09; 74(3):343-7. PubMed ID: 3561887
    [Abstract] [Full Text] [Related]

  • 3. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
    Crawley JH.
    Prog Clin Biol Res; 1985 Mar 09; 192():131-8. PubMed ID: 4080706
    [Abstract] [Full Text] [Related]

  • 4. Non-opiate beta-endorphin fragments and dopamine--VI. Behavioural analysis of the interaction between gamma-type endorphins and dopaminergic systems in the nucleus accumbens of rats.
    Király I, Van Ree JM.
    Neuropharmacology; 1984 May 09; 23(5):511-6. PubMed ID: 6204246
    [Abstract] [Full Text] [Related]

  • 5. gamma-Endorphin and N alpha-acetyl-gamma-endorphin interfere with distinct dopaminergic systems in the nucleus accumbens via opioid and non-opioid mechanisms.
    van Ree JM, Gaffori O, Kiraly I.
    Life Sci; 1984 Apr 02; 34(14):1317-24. PubMed ID: 6200747
    [Abstract] [Full Text] [Related]

  • 6. Uniquely, gamma-endorphin induces an effect that is both opiate- and neuroleptic-like.
    van Ree JM, Gaffori O.
    Life Sci; 1983 Apr 02; 33 Suppl 1():619-22. PubMed ID: 6198576
    [Abstract] [Full Text] [Related]

  • 7. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function.
    Vaccarino FJ, Rankin J.
    Behav Neurosci; 1989 Aug 02; 103(4):831-6. PubMed ID: 2765186
    [Abstract] [Full Text] [Related]

  • 8. Non-opiate beta-endorphin fragments and dopamine--III. gamma-Type endorphins and various neuroleptics counteract the hypoactivity elicited by injection of apomorphine into the nucleus accumbens.
    Van Ree JM, Caffé AR, Wolterink G.
    Neuropharmacology; 1982 Nov 02; 21(11):1111-7. PubMed ID: 6184640
    [Abstract] [Full Text] [Related]

  • 9. Interaction of dopamine agonists with disrupted mesolimbic pathways implications for mental health.
    Wray SR, Melville GN, Wenger T, Louden D.
    West Indian Med J; 1984 Jun 02; 33(2):106-16. PubMed ID: 6541399
    [No Abstract] [Full Text] [Related]

  • 10. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
    Crawley JN, Stivers JA, Hommer DW, Skirboll LR, Paul SM.
    J Pharmacol Exp Ther; 1986 Feb 02; 236(2):320-30. PubMed ID: 3003339
    [Abstract] [Full Text] [Related]

  • 11. Non-opiate beta-endorphin fragments and dopamine-IV. gamma-Type endorphins may control dopaminergic systems in the nucleus accumbens.
    Van Ree JM, Wolterink G, Fekete M, De Wied D.
    Neuropharmacology; 1982 Nov 02; 21(11):1119-27. PubMed ID: 6184641
    [Abstract] [Full Text] [Related]

  • 12. The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens.
    Radhakishun FS, Van Ree JM.
    Eur J Pharmacol; 1987 May 07; 137(1):41-7. PubMed ID: 3609134
    [Abstract] [Full Text] [Related]

  • 13. In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents.
    Van Ree JM, Gaffori O, De Wied D.
    Eur J Pharmacol; 1983 Sep 16; 93(1-2):63-78. PubMed ID: 6138272
    [Abstract] [Full Text] [Related]

  • 14. Effect of a novel environment on locomotor hyperactivity of rats induced by apomorphine in the nucleus accumbens.
    Morgenstern R, Fink H.
    Biomed Biochim Acta; 1985 Sep 16; 44(10):1517-22. PubMed ID: 4084255
    [Abstract] [Full Text] [Related]

  • 15. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
    Weiss F, Ettenberg A, Koob GF.
    Psychopharmacology (Berl); 1989 Sep 16; 99(3):409-15. PubMed ID: 2574480
    [Abstract] [Full Text] [Related]

  • 16. Electrophysiological effects of cholecystokinin: central dopaminergic systems.
    Wang RY, White FJ.
    Prog Clin Biol Res; 1985 Sep 16; 192():95-103. PubMed ID: 4080721
    [Abstract] [Full Text] [Related]

  • 17. Beta-endorphin-(10-16) antagonizes behavioral responses elicited by melatonin following injection into the nucleus accumbens of rats.
    Gaffori O, van Ree JM.
    Life Sci; 1985 Jul 29; 37(4):357-64. PubMed ID: 3159948
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity.
    Kalivas PW, Widerlöv E, Stanley D, Breese G, Prange AJ.
    J Pharmacol Exp Ther; 1983 Oct 29; 227(1):229-37. PubMed ID: 6620168
    [Abstract] [Full Text] [Related]

  • 20. [Circling behavior produced by the unilateral intra-accumbens injection of dopaminergic agonist and two dopaminergic antagonists in mice].
    Mrabet O, Messier C, Destrade C.
    C R Acad Sci III; 1989 Oct 29; 309(3):77-82. PubMed ID: 2504444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.